Integrated Research logo

Integrated Research(ASX) IRI

Market CapA$50.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)-34%
5 Year-78%
1 Year-13%
1 Month-4%
A$0.28
+0.00%
+0.00Today
Integrated Research last closing stock price
MetricPriceDate
Last closeAUD 0.282026-10-13
Integrated Research stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%AUD 0.282026-10-06
1 month-3.51%AUD 0.292026-09-10
3 month+8.26%AUD 0.252026-07-15
Year to date-8.76%AUD 0.302025-12-31
1 year-12.51%AUD 0.312025-10-13
3 year+4.88%AUD 0.262023-10-13
5 year-78.23%AUD 1.262021-10-14
Since inception-34.09%AUD 0.422000-12-13

Integrated Research Financials at a Glance

Market Cap

A$50.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$125.89M

Net Income (TTM)

A$14.57M

EPS (TTM)

A$0.01

P/E Ratio

41.04

Dividend

A$0.03

Beta (Volatility)

0.18 (Low)

Price

A$0.28

Volume

44,133

Open

A$0.28

Previous Close

A$0.28

Daily Range

A$0.27 - A$0.28

52-Week Range

A$0.26 - A$0.37

Estimated Earnings Date

Feb 24, 2027

IRI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Integrated Research

Integrated Research Limited is an Australian software company founded in 1988, specializing in solutions for managing critical IT systems. The company offers a comprehensive suite of software products designed to enhance operational insights across various platforms, including payment networks and unified communications.

Products and Services
  • Prognosis software suite for IT system management
  • Software-as-a-Service (SaaS) options for flexible deployment
  • Professional services including testing and maintenance
Growth Outlook
  • Revenue increased to AUD 29.29 million in the latest quarter
  • Net income reached AUD 2.74 million, reflecting operational efficiency
  • Strong cash flow generation with AUD 8.75 million from operating activities
Financial Highlights
  • Trailing twelve months revenue of AUD 113.5 million
  • Dividend yield of 18.18%, indicating strong shareholder returns
  • Current ratio of 4.54, showcasing robust liquidity position
Integrated Research Limited operates globally, serving clients in approximately 60 countries. The company's flagship product, Prognosis, is pivotal for businesses that rely on critical IT infrastructure, such as financial institutions and telecommunications providers. The recent financial performance indicates a positive trajectory, with significant revenue growth and a solid net income, underscoring the company's operational effectiveness. The strong cash flow from operations further enhances its financial stability, allowing for continued investment in product development and market expansion. With a high dividend yield, Integrated Research Limited presents an attractive opportunity for investors seeking exposure to the technology sector.
AI Generated • Oct 2, 2026

Industry

Software

Employees

138

CEO

Ian Lowe

Website

www.ir.com

Headquarters

Sydney, NSW 2000, AU

IRI Financials

Key Financial Metrics (TTM)

Gross Margin

46.57%

Operating Margin

-2.06%

Net Income Margin

2.10%

Return on Equity

1.25%

Return on Capital

-1.19%

Return on Assets

1.01%

Earnings Yield

2.44%

Dividend Yield

10.91%

Payout Ratio

2.93%

Stock Overview

Market Cap

A$50.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

182.39M

Volume

44.13K

Avg. Volume

115.72K

Financials (TTM)

Gross Profit

A$77.52M

Operating Income

A$12.18M

EBITDA

A$12.61M

Operating Cash Flow

A$24.80M

Capital Expenditure

-A$754.00K

Free Cash Flow

A$24.04M

Cash & ST Invst.

A$51.69M

Total Debt

A$1.52M

Integrated Research Performance Analysis

Integrated Research annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 69,828,00011.1%
20242024-06-30AUD 83,292,00019.3%
20252025-06-30AUD 68,256,000-18.1%
20262026-06-30AUD 57,638,000-15.6%
Integrated Research sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-32.1%
Q42025-06-3036.7%
Q22025-12-31-28.1%
Q42026-06-303.3%
Integrated Research annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.17N/A
20242024-06-30AUD 0.15N/A
20252025-06-30AUD 0.07-51.1%
20262026-06-30AUD 0.01-91.1%
Integrated Research sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-70.9%
Q42025-06-3091.0%
Q22025-12-31-117.5%
Q42026-06-30278.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$29.29M

-31.0%

Gross Profit

A$14.46M

-36.5%

Gross Margin

49.36%

N/A

Market Cap

A$50.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$363.46K

N/A

Employees

138

N/A

Net Income

A$2.74M

-82.8%

EBITDA

A$2.19M

-85.3%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$51.69M

+62.1%

Total Debt

A$1.52M

-11.3%

Accounts Receivable

A$37.54M

-12.7%

Inventory

A$0.00

N/A

Long Term Debt

A$985.00K

+163.4%

Short Term Debt

A$536.00K

-60.0%

Return on Assets

1.01%

N/A

Return on Invested Capital

-1.18%

N/A

Free Cash Flow

A$8.64M

-10.0%

Operating Cash Flow

A$8.75M

-9.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UBN.AXUrbanise.com Limited
A$0.63+0.00%
NVU.AXNanoveu Limited
A$0.05-2.00%
RKN.AXReckon Limited
A$0.42+0.00%
SMN.AXStructural Monitoring Systems Plc
A$0.35+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
BMBLBumble
$5.94+56.32%
CIFRCipher Digital
$11.63-10.58%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$38.20+2.72%
JBDIJbdi
$7.04+604.42%

Questions About IRI

What is the current price of Integrated Research?

Integrated Research is trading at A$0.28 per share.

What is the 52-week range for Integrated Research?

Over the past 52 weeks, Integrated Research has traded between A$0.26 and A$0.37.

How much debt does Integrated Research have?

As of the most recent reporting period, Integrated Research reported total debt of A$1.52M.

How much cash does Integrated Research have on hand?

Integrated Research reported A$51.69M in cash and cash equivalents in its most recent financial results.

What is Integrated Research’s dividend yield?

Integrated Research currently has a dividend yield of 10.91%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.